Free Trial
NASDAQ:ACCD

Accolade (ACCD) Stock Price, News & Analysis

Accolade logo
$7.02 0.00 (0.00%)
As of 04/8/2025

About Accolade Stock (NASDAQ:ACCD)

Key Stats

Today's Range
$7.02
$7.02
50-Day Range
$6.89
$7.03
52-Week Range
$3.08
$9.41
Volume
N/A
Average Volume
1.47 million shs
Market Capitalization
$575.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.51
Consensus Rating
Hold

Company Overview

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Accolade Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

ACCD MarketRank™: 

Accolade scored higher than 44% of companies evaluated by MarketBeat, and ranked 190th out of 321 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Accolade has received a consensus rating of Hold. The company's average rating score is 2.07, and is based on 1 buy rating, 13 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Accolade has only been the subject of 2 research reports in the past 90 days.

  • Read more about Accolade's stock forecast and price target.
  • Earnings Growth

    Earnings for Accolade are expected to grow in the coming year, from ($1.20) to ($0.86) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Accolade is -3.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Accolade is -3.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Accolade has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.71% of the float of Accolade has been sold short.
  • Short Interest Ratio / Days to Cover

    Accolade has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Accolade has recently increased by 30.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Accolade does not currently pay a dividend.

  • Dividend Growth

    Accolade does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.71% of the float of Accolade has been sold short.
  • Short Interest Ratio / Days to Cover

    Accolade has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Accolade has recently increased by 30.13%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Accolade this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Accolade insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $71,422.00 in company stock.

  • Percentage Held by Insiders

    Only 8.20% of the stock of Accolade is held by insiders.

  • Percentage Held by Institutions

    84.99% of the stock of Accolade is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Accolade's insider trading history.
Receive ACCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

ACCD Stock News Headlines

Accolade (ACCD) to Release Quarterly Earnings on Thursday
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Transcarent Completes Merger With Accolade
Accolade announces stockholder approval for Transcarent merger
See More Headlines

ACCD Stock Analysis - Frequently Asked Questions

Accolade's stock was trading at $3.42 at the beginning of 2025. Since then, ACCD shares have increased by 105.3% and is now trading at $7.02.
View the best growth stocks for 2025 here
.

Accolade, Inc. (NASDAQ:ACCD) announced its earnings results on Friday, January, 10th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.01. Accolade had a negative net margin of 40.36% and a negative trailing twelve-month return on equity of 20.74%.

Accolade (ACCD) raised $176 million in an initial public offering on Thursday, July 2nd 2020. The company issued 8,800,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities acted as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

Top institutional investors of Accolade include SG Americas Securities LLC (0.07%) and Wealth Enhancement Advisory Services LLC (0.02%). Insiders that own company stock include Stephen H Barnes, Robert N Cavanaugh, Michael W Hilton, Richard Eskew and Colin Mchugh.
View institutional ownership trends
.

Shares of ACCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Accolade investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), Humana (HUM), The RMR Group (RMR) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
1/10/2025
Today
4/25/2025
Fiscal Year End
2/28/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Current Symbol
NASDAQ:ACCD
Fax
N/A
Employees
2,350
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.51
High Stock Price Target
$8.00
Low Stock Price Target
$5.00
Potential Upside/Downside
-7.3%
Consensus Rating
Hold
Rating Score (0-4)
2.07
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-99,810,000.00
Pretax Margin
-39.96%

Debt

Sales & Book Value

Annual Sales
$446.72 million
Price / Cash Flow
N/A
Book Value
$5.75 per share
Price / Book
1.22

Miscellaneous

Free Float
74,896,000
Market Cap
$575.59 million
Optionable
Optionable
Beta
2.10

Social Links

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ACCD) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners